{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:01:49Z","timestamp":1791910909763,"version":"4.3.4"},"reference-count":50,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Objectives<\/jats:title>\n                    <jats:p>Opioid maintenance treatment (OMT), with methadone or buprenorphine, is a key approach for managing opioid use disorder (OUD) during pregnancy. Despite buprenorphine's superior short\u2010term outcomes, its long\u2010term effects remain understudied. This study aims to evaluate the effects of prenatal OMT exposure on the incidence of childhood neurodevelopmental disorders (NDDs) considering timing effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study using Rhode Island Medicaid data linked to vital statistics from 2008 to 2018 was conducted. The study included pregnancies having live birth from 2008 to 2016 with continuous Medicaid insurance and OUD diagnosis within 3\u2009months preceding conception until delivery. At least one buprenorphine dispensing or a claim of methadone was required for exposure definition. Exposure was evaluated during early (0\u201390\u2009days) or late (&gt;90\u2009days) gestation, or at any pregnancy phase. NDDs, including autism, attention\u2010deficit\/hyperactivity disorder (ADHD), learning disabilities, speech\/language disorders, developmental coordination disorder, intellectual disability, and behavioral disorders, were identified using validated algorithms. Applying Cox proportional\u2010hazard models with propensity score overlap weighting, adjusted hazard ratios (aHR) were calculated, mitigating potential confounders. Children were followed up from birth until NDD diagnosis, disenrollment, or study end.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 416 mother\u2013child dyads with OUD, 40% used methadone and 20% had buprenorphine exposure during pregnancy. NDDs were observed in 36% of children with early methadone exposure compared to 17% in the early buprenorphine exposed group (aHR: 2.75; 95% confidence interval [CI]: 1.42\u20135.35). Further comparison to late buprenorphine exposure, late methadone exposure was associated with higher NDD risk (aHR: 2.05; 95% CI: 1.09\u20133.86). Compared to unexposed group, children exposed to methadone during early and late periods showed higher NDD incidences (aHR: 2.33; 95% CI: 1.51\u20133.60 and aHR: 2.42; 95% CI: 1.54\u20133.80, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The study suggests that buprenorphine is a good treatment option for OUD during pregnancy due to minimal long\u2010term neurodevelopmental impacts on children. However, further extensive research is necessary to rule\u2010out potential confounding.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/phar.4616","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T03:33:55Z","timestamp":1729136035000},"page":"770-781","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Neurodevelopmental outcomes in children prenatally exposed to opioid maintenance treatment: A population\u2010based study"],"prefix":"10.1002","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6604-063X","authenticated-orcid":false,"given":"Mennatullah","family":"Hasan","sequence":"first","affiliation":[{"name":"Pharmacy Practice, College of Pharmacy University of Rhode Island  Kingston Rhode Island USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7471-882X","authenticated-orcid":false,"given":"Kimford J.","family":"Meador","sequence":"additional","affiliation":[{"name":"Department of Neurology Stanford University  California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1799-7233","authenticated-orcid":false,"given":"Todd N.","family":"Brothers","sequence":"additional","affiliation":[{"name":"Pharmacy Practice, College of Pharmacy University of Rhode Island  Kingston Rhode Island USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[{"name":"Pharmacy Practice, College of Pharmacy University of Rhode Island  Kingston Rhode Island USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8706-1409","authenticated-orcid":false,"given":"Adam K.","family":"Lewkowitz","sequence":"additional","affiliation":[{"name":"Maternal Fetal Medicine, Women and Infants Hospital of Rhode Island Alpert Medical School of Brown University  Providence Rhode Island USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6720-3035","authenticated-orcid":false,"given":"Kristina E.","family":"Ward","sequence":"additional","affiliation":[{"name":"Pharmacy Practice, College of Pharmacy University of Rhode Island  Kingston Rhode Island USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6831-7520","authenticated-orcid":false,"given":"Jonathan L.","family":"Slaughter","sequence":"additional","affiliation":[{"name":"Nationwide Children's Hospital and The Ohio State College of Medicine  Columbus Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Computer Science and Statistics University of Rhode Island  Kingston Rhode Island USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-7895","authenticated-orcid":false,"given":"Xuerong","family":"Wen","sequence":"additional","affiliation":[{"name":"Pharmacy Practice, College of Pharmacy University of Rhode Island  Kingston Rhode Island USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2020.8848"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000472"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2015.95"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2018.10.010"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318256496e"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1515\/jpm-2020-0106"},{"key":"e_1_2_8_8_1","unstructured":"Buprenorphine versus methadone for opioid use disorder in pregnancy|NEJM. Accessed January 5 2023.https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2203318."},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.11.030"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6105.1000263"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2021.107000"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/09297049.2011.553591"},{"issue":"6","key":"e_1_2_8_13_1","first-page":"35","article-title":"Prescription opioid use among pregnant women enrolled in Rhode Island medicaid","volume":"102","author":"Wen X","year":"2019","journal-title":"R I Med J (2013)"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-813X(01)00092-4"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1105183"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5369"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-021-01080-0"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.108.051672"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-1434"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.1195"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20622"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwy201"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1694729"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2011.642758"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-06339-3"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2006.pto_329.x"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwu190"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000253"},{"key":"e_1_2_8_29_1","first-page":"dyw277","volume-title":"Explanation in Causal Inference: Methods for Mediation and Interaction","author":"VanderWeele T","year":"2015"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2607"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.14117"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.14808"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.04040.x"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.1.60"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1978.tb12431.x"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/15353702221090457"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1162\/0898929041920441"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2012.04.008"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/eep\/dvv012"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2008.108"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1159\/000210042"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.4103\/0976-3147.91934"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0329-5"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.whi.2016.09.002"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.13113"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2018.05162"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmab154"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1037\/amp0000675"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-019-0158-0"},{"key":"e_1_2_8_50_1","unstructured":"HFA04OpioidUseDisorders.2017Accessed November 7 2022.https:\/\/eohhs.ri.gov\/sites\/g\/files\/xkgbur226\/files\/Portals\/0\/Uploads\/Documents\/SIM\/HFA04OpioidUseDisorders.pdf"},{"key":"e_1_2_8_51_1","unstructured":"Neurodevelopmental Disorders.2015."}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.4616","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T16:46:48Z","timestamp":1761065208000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.4616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1002\/phar.4616"],"URL":"https:\/\/doi.org\/10.1002\/phar.4616","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"2024-06-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}